Yahoo! Video requires a more recent version of the Adobe Flash Player.
-
My Video
-
Oops, you have to be signed in to get to your My Video Page.
Sign in Now -
Don't have a Yahoo! ID?
Sign Up
-
TAXUS Libert Paclitaxel-Eluting Stent expanding in a coronary artery
Published 52 days ago
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its second-generation TAXUS Libert Paclitaxel-Eluting Coronary Stent System. The Company plans to launch... more
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its second-generation TAXUS Libert Paclitaxel-Eluting Coronary Stent System. The Company plans to launch the TAXUS Libert stent early next month in the United States, following completion of the introduction of its TAXUS Expresss2 Atom Paclitaxel-Eluting Coronary Stent System, which was approved by the FDA last month. The TAXUS Libert stent was launched in Europe and other international markets in 2005. To view Multimedia News Release go to, http://www.prnewswire.com/mnr/bsci/34446/ less
- Category: News & Politics
LOADING
LOADING
Yahoo! Video
More With Video
Tell us what you think about Yahoo! Video - Send us your feedback
Copyright © 2008 Yahoo! Inc. All rights reserved.
Comments (0)
LOADING
Add a new comment
Your reply